Snoop Dogg's Casa Verde gets into the sleep space, backing NY-based Proper

Jonathan Shieber
·4 mins read

Helping Americans get their 40 winks has never been more necessary as the country faces what some health experts have called a sleep epidemic, and Snoop Dogg's cannabis-focused firm Casa Verde Capital wants to help.

The firm is leading a $9.5 million investment into a company called Proper, which is launching with a combination of sleep coaching and supplements, pitching a "holistic" sleep health solution.

One-third of U.S. adults don't get enough sleep according to Proper's estimates, and the company's chief executive, Nancy Ramamurthi, says that the COVID-19 epidemic has only made the problem worse.

"Proper aims to help solve what the CDC has identified as a public health crisis -- insufficient sleep -- with a truly more holistic and personalized solution,” said Ramamurthi, founder and CEO of Proper, in a statement. “Proper has combined the best of natural, safe, evidence-based sleep supplements with expert behavioral coaching, which consumers have not traditionally been able to access. Now, thanks to the increasing popularity of telehealth, sleep coaching can be delivered online."

The sleep coaching services from Proper are provided by board-certified health and wellness coaches under the guidance of a clinical psychologist and behavioral sleep medicine specialist, according to a statement from the company.

Ramamurthi said that clinical validation is a core component of the company's business. Indeed, the company is currently running its formulations through a clinical trial to prove their efficacy. It's an additional step that the company doesn't need to take, she said, because the supplements have all been studied with clinical trials supporting the use of the ingredients as treatments for sleep therapy. "That's in addition to them being used for thousands of years," said Ramamurthi.

Proper was incubated within the consumer health venture studio Redesign Health and will use the new capital from investors led by Snoop Dogg's Casa Verde to boost its sales and marketing efforts and continue its research and development activities.

While sleep aids may seem like a strange market for a cannabis-focused investment firm, Casa Verde partner Karan Wadhera says it's a highly strategic investment for the firm.

"[Cannabis] is an input as well and its use case will go beyond how people think of cannabis stigmatically," Wadhera said. "At its core, [Proper] is a company that’s helping us target this sleep epidemic. We think CBD and cannabis at large can play a big role in addressing that in a way that traditional products haven’t been able to."

The investment in Proper, then, points to a maturation of the cannabis industry, as investors look at the various chemical components of the cannabis plant and try to tease out a broader range of health and wellness applications. "We are starting to shift how we think about the business. It doesn’t have to be a core, specific cannabis product," Wadhera said.

Image Credits: Proper

Ramamurthi says that her company will be exploring applications for cannabinoids in its supplements later. "As we continue our product development process one of the things we are looking at is CBD," she said. "CBD is one of the more effective ingredients at reducing stress and anxiety, and stress and anxiety are one of the main reasons why people can’t get to sleep."

Proper's studies are supported by a scientific advisory board that includes Dr. Adam Perlman, the director of integrative health and well-being at the Mayo Clinic, and Dr. Allison Siebern, a clinical psychologist and board-certified sleep medicine specialist at the VA Medical Center in North Carolina.

There's a reason why sleep is so poorly understood and ignored as a health issue in America. Around 90% of primary care physicians rate their understanding of sleep's impact on the body as "poor to fair" and there's only one board-certified sleep specialist for every 43,000 Americans, according to Proper's data.

Customers who sign up for Proper's service can select one of five sleep formulations available for $39.99 per bottle or for a subscription with a 10% discount. New users also get a free 30-minute consultation with a Proper sleep coach, the company said.

The five versions of Proper's sleep products include a core sleep product made from GABA, valerian root extract, rafuma leaf extract, and ashwagandha root and leaf extract; a sleep and restore product that includes melatonin; a calming pill with L-theanine added to the core sleep product; a clarity product that includes concentrated grape extracts; and, finally, an immunity product with added zinc, vitamin C, B6 and D.

More From

  • Elon Musk says 'embarrassingly late' two-factor is coming to Tesla app

    Tesla CEO Elon Musk acknowledged Friday that the company was ‘embarrassingly late’ rolling out a security layer known as two-factor authentication for its mobile app. Musk said in April that the additional security layer was "coming soon."

  • Clearview AI landed a new facial recognition contract with ICE

    The controversial facial recognition software maker Clearview AI has a new contract with ICE, the most controversial U.S. government agency. Clearview was already known to work with the branch of Homeland Security fiercely criticized for implementing the Trump administration's harsh immigration policies. The new contract makes it clear that relationship is ongoing — and that Clearview isn't just playing a bit part in tech's lucrative scrum for federal contracts.

  • Birmingham-based Help Lightning raises $8 million for its remote training and support tools

    In the four years since Help Lightning first began pitching its services out of its Birmingham, Ala. headquarters, the company has managed to sign up 100 customers including some large Fortune 500 companies like Cox Communications, Siemens, and Boston Scientific. Now, with an additional $8 million in financing from Resolve Growth Partners, the company is hoping to expand its sales and marketing efforts and continue to refine its product. The technology was initially invented by Bart Guthrie, a neurosurgeon at the University of Alabama at Birmingham, who wanted a way to improve telepresence technologies so he could assist with remote surgeries.

  • Sequoia Capital has internal crash courses for its founders -- here's how they work

    No matter what you think of Sequoia Capital, the firm doesn't rest on its laurels. Recently, to create more room between itself and its ever-growing number of competitors, the firm has also begun fine-tuning a curriculum for the founders of both the pre-seed and seed-stage startups it has funded, as well as its Series A and B-stage founders. According to Roelof Botha -- the U.S. head of the venture firm since 2017 -- and Jess Lee, a partner at Sequoia for nearly four years, the idea is to arm the individuals it backs with Sequoia's vast "tribal knowledge" so they can not only compete with their rivals but, hopefully, outperform them.